CLINICAL TRIALS PROFILE FOR CEVIMELINE HYDROCHLORIDE
✉ Email this page to a colleague
All Clinical Trials for CEVIMELINE HYDROCHLORIDE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00017511 ↗ | Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer | Completed | Daiichi Sankyo Inc. | Phase 3 | 2001-06-01 | RATIONALE: Cevimeline may be effective in treating dry mouth that is caused by radiation therapy for head and neck cancer. It is not yet known if cevimeline is more effective than no therapy in treating dry mouth caused by radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of cevimeline in treating patients who have dryness of the mouth caused by radiation therapy for head and neck cancer. |
| NCT00017511 ↗ | Cevimeline in Treating Patients With Dry Mouth Caused by Radiation Therapy for Head and Neck Cancer | Completed | Daiichi Sankyo, Inc. | Phase 3 | 2001-06-01 | RATIONALE: Cevimeline may be effective in treating dry mouth that is caused by radiation therapy for head and neck cancer. It is not yet known if cevimeline is more effective than no therapy in treating dry mouth caused by radiation therapy. PURPOSE: Randomized phase III trial to determine the effectiveness of cevimeline in treating patients who have dryness of the mouth caused by radiation therapy for head and neck cancer. |
| NCT00466388 ↗ | Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced Xerostomia | Completed | Duke University | Phase 4 | 2007-05-01 | The purpose of this study is to determine the effectiveness of cevimeline (versus placebo) on the oral health of patients who have dry mouth which was caused by radiation therapy that was given for treatment of head and/or neck cancer. |
| NCT00466388 ↗ | Study of the Effectiveness of Cevimeline on Oral Health in Patients With Radiation Induced Xerostomia | Completed | American Academy of Otolaryngology-Head and Neck Surgery Foundation | Phase 4 | 2007-05-01 | The purpose of this study is to determine the effectiveness of cevimeline (versus placebo) on the oral health of patients who have dry mouth which was caused by radiation therapy that was given for treatment of head and/or neck cancer. |
| NCT01690052 ↗ | Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva | Completed | University of Kentucky | N/A | 2009-01-01 | The main objectives were: 1) To determine the efficacy of both cevimeline and pilocarpine in the secretion of saliva in patients with xerostomia, and 2) To compare the side-effects between the treatment for xerostomia with cevimeline and with pilocarpine. |
| NCT01903109 ↗ | Crossover Bioequivalence Study of Cevimeline 30 mg Capsules Under Fed Conditions | Completed | Roxane Laboratories | Early Phase 1 | 2009-02-01 | The objective of this study was to prove the bioequivalence of Roxane Laboratories' Cevimeline 30 mg under fed conditions |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CEVIMELINE HYDROCHLORIDE
Condition Name
Clinical Trial Locations for CEVIMELINE HYDROCHLORIDE
Trials by Country
Clinical Trial Progress for CEVIMELINE HYDROCHLORIDE
Clinical Trial Phase
Clinical Trial Sponsors for CEVIMELINE HYDROCHLORIDE
Sponsor Name
